May 2016

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Ongoing All Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation (RWJF)
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Development of data and evidence needed to advance a Culture of Health.  Research could:
(1) Provide evidence for factors in the Action Framework that are believed - but not yet proven to impact health; (2) Reframe or challenge existing ideas; (3) Integrate existing data and methods across disciplines and sectors; and/or (4) Identify actions that can improve health for marginalized populations.
Due Dates: Applicants can expect notification w/in 6-8 weeks of a 2-page Letter of Intent submission. Invited applicants will have 2 months to submit a proposal. Funding decisions will generally be made within 6-8 weeks of the full submission.
Amount & Project Period: ~$200,000 - up to 30 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2015 Call For Proposals

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03


Ongoing All Ranks Federal See BAA

United States Army Medical Research and Materiel Command (USAMRMC) Broad Agency Announcement for Extramural Medical Research
W81XWH-16-R-BAA1

The mission of the USAMRMC is to provide solutions to medical problems of importance.  Projects must be for basic and applied research. Projects must be for scientific study and experimentation directed toward advancing the state of the art or increasing knowledge or understanding.  (See general description of research and development programs, including research areas of interest in the announcement.)
Due Dates: Open continuously from Oct. 01, 2015 through Sept. 30, 2016. Organizations are required to submit pre-proposals/pre-applications. 
Amount & Project Period: Budgets are not limited - up to 5 years
Eligibility: All individuals, regardless of ethnicity, nationality, or citizenship status, employed by, or affiliated with, an eligible organization.
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-16-R-BAA1


Rolling All Ranks Non-federal Pediatric

Thrasher Research Fund
E.W. "Al" Thrasher Awards

Ideal applications address significant health problems that affect children in large numbers and offer the potential for practical solutions to these problems.  Such solutions sh/be innovative and have potential for broad applicability w/low financial and/or technical barriers to implementation.  Hypothesis-driven research is preferred over exploratory, hypothesis-generating research. Projects with a shorter distance to clinical applicability are given priority.
Due Dates: Concept papers accepted on a rolling basis, and time from submission to decision is 1-6 weeks.  Submission of full proposal is allowed up to 1 year after approval of concept.  Review and response on proposal can take about 4 months.  Proposals and reviews are submitted to Committees at the beginning of February and August and final decisions are made in late March and late September.  For a September decision, concept papers should be submitted in April to allow sufficient time for the process.
Amount & Project Period: Grant amount is based on the actual budgetary needs of the project - Up to 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidance
U01 NCI

NEW
April 19 (LOI) All Ranks Federal Tissue Engineering

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research

This FOA will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Supported projects will establish and collectively participate in the Cancer Tissue Engineering Collaborative (TEC) Research Program.
Due Dates: Apr. 19 (Letter of Intent)
May 29 (OSR) Ι May 31 (Sponsor)
Additional Due Dates: Nov. 30; May 30 & Nov.30, 2017; and May 30 & Nov. 30, 2018 (LOI due 6 weeks prior to due date)
Amount & Project Period: $400,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-105


April 19 Clinical Faculty Non-federal Career Development

Robert Wood Johnson Foundation
Clinical Scholars Program

This program provides a fellowship for clinically active health care providers spanning a range of disciplines. It aims to provide clinicians with the opportunity to build and develop the unique skills needed to lead communities toward a Culture of Health.  Strong applicants will bring a knowledge of and experience in the art and science of health care services, a unique perspective as providers on health and health care systems, and a special professional status and relationship with patients and communities.
Due Dates: Apr. 15 (OSR) Ι Apr. 19 (Sponsor)
Amount & Project Period: $105,000 - 3 years
Eligibility: Clinically active health care providers
Completed all required clinical training >5 years prior to applying;
Will be fully licensed in chosen profession or be doctorally prepared and have a clinical master's degree;
Have substantial community-focused research or program experience;
Must be U.S. citizens, permanent residents, or individuals granted DACA status.
Contact: Office of Sponsored Research (x6804)
Links: Overview  Ι 2016 Call for Applications

April 21 (Pre-application) See Below Federal Breast

Congressionally Directed Medical Research Programs
Breast Cancer Research Program

Due Dates: Apr. 21 (Pre-application)
Full Applications Due: May 03 (OSR) Ι May 05 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: FY16 Breast Cancer Research Program
https://eBRAP.org (Pre-app.)
Breakthrough Fellowship Award (NEW!)
W81XWH-16-BCRPBREAKTHROUGH_FELLOWSHIP

Supports talented recent doctoral or medical graduates in pursuit of promising research having potential to lead to or make breakthroughs in breast cancer. Potential impact may be near-term or long-term, but must be significant and go beyond an incremental advancement. Individualized training program and mentorship should prepare PI for an independent career at the forefront of breast cancer research or patient care. PI is not required to have previous experience in breast cancer research.
Amount & Project Period: $300,000 (Direct Costs) - 3 years
Eligibility: As of application deadline candidate will have:
Successfully completed requirements for a doctoral or medical degree, and been in laboratory or clinical research setting in which proposed research is to be performed for no more than 2 years.
A total of less than 4 years' experience in a postdoctoral fellowship or mentored clinical research training program (excludes any clinical residency or fellowship training).
Mentor must have breast cancer research experience, including current funding and recent publications
Link: Program Announcement
 

Breakthrough Award Levels 1 and 2
W81XWH-16-BCRP-BREAKTHROUGH_FL12

Supports promising research that has potential to lead to or make breakthroughs in breast cancer. Potential impact may be near-term or long-term, but must be significant and go beyond an incremental advancement. Partnering PI Option allows 2 PIs (termed Initiating and Partnering PIs) to collaborate on a single application.
Amount & Project Period: Requested funding level should be based on scope of research proposed.
Level 1:  $375,000 (Direct Costs) - 3 years
Level 1 (Ptnr. PI):  $600,000 (Direct Costs) - 3 years (A separate award will be made to each PI's institution.)
Level 2:  $750,000 - 3 years
Level 2 (Ptnr. PI):  $1.0M - 3 years (A separate award will be made to each PI's institution.)
Eligibility: Investigators at all academic levels (or equiv.) Senior postdoctoral fellows who do not meet the eligibility requirements of the Breakthrough Fellowship Award are encouraged to apply under Funding Levels 1 and 2.
Link: Program Announcement
 

Era of Hope Scholar Award
W81XWH-16-BCRP-EOHS

Supports talented, creative early-career scientists Proposals should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. PIs should exhibit strong potential for leadership in the breast cancer community.
Amount & Project Period: $2.5M (Direct Costs) - 4 years
Eligibility: Independent, non-mentored investigators w/in 6 years of last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of application submission deadline.
Link: Program Announcement

April 22, 5:00 Women & Minority Investigators Non-federal Cutaneous Malignancies

Moffitt Skin Cancer SPORE
Career Enhancement Program & Developmental Research Program

Developmental Research Program (DRP) The DRP promotes the exploration of innovative ideas in translational cutaneous malignancy research through the funding of pilot projects.
Career Enhancement Program (CEP) The CEP will be used to prepare female and/or minority investigators at the rank of Assistant Member particular those already in the field of cutaneous malignancy research, or established investigators at the rank of Associate Member or higher who are new to the field for careers in translational research of cutaneous malignancies. 
Due Dates: Apr. 22, (5:00 pm)
Email applications to awards@moffitt.org, Office of Sponsored Research at least two days prior to the deadline
Amount & Project Period: Amount awarded will depend on costs of science proposed, innovation, and potential for further funding of research.  Performance period is one (1) year.
Eligibility: Investigators must be female and/or of racial or ethnic minority as defined by the NIH.
Links: Updated Guidelines  Ι  Updated Application 

April 22 (LOI) All Faculty Non-federal Lung

Free to Breathe
2016 Metastasis Research Grant  To Prevent or Stop Lung Cancer Metastasis

Letters of Intent (LOIs) are solicited that propose research to prevent or stop lung cancer metastasis and include a clear vision and plan for clinical translation.   Awards will support high-impact, innovative lung cancer research within this area of emphasis that will result in clinical translation (e.g. clinical trial).   Proposals with interdisciplinary, collaborative teams and two or more PIs are encouraged.
Due Dates: Apr. 22, 5:00pm (EST) (Letter of Intent)
Invited Submissions:  Aug. 13 (OSR) Ι Aug. 15 (Sponsor)
Amount & Project Period: $600,000 (TOTAL) - 3 years
Eligibility: Must be independent investigators at or above the level of Assistant Professor (or equivalent)
Need not be US citizen; however work visa verification required Applications only accepted from PIs engaged in non-small cell or small cell lung cancer research
Contact: Office of Sponsored Research - (x6804)
Links: Overview Ι RFP Ι Submission Site
U54 NCI

NEW
April 23 (LOI) All Ranks Federal Translational

Research Centers for Barrett's Esophagus Translational Research Network (BETRNet) (U54)  

This FOA solicits applications for multi-institutional, trans-disciplinary, translational Research Centers to serve as the main units of the Barrett's Esophagus Translational Research Network (BETRNet) which is an NCI program established to address the rising incidence of esophageal adenocarcinoma.  Specifically, the program seeks a better understanding of the biology of esophageal adenocarcinoma and its precursor lesion, Barrett's esophagus, as the foundation for validated preventive measures that would improve patient management.
Due Dates: Apr. 23 (Letter of Intent)
May 19 (OSR) Ι May 23 (Sponsor)
Amount & Project Period: $900,000/yr.  (Direct Costs) - 5 years
Eligibility: All Ranks - Given the required multi-disciplinary and multi-institutional teams, applicants are encouraged to take advantage of the multiple PDs/PIs option
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-006
Companion RFA: RFA-CA-16-007 (BETRNet Coordinating Center) (U24)
U01 NCI

NEW
April 25 (LOI) All Ranks Federal Biomarker Development

The Early Detection Research Network: Biomarker Developmental Laboratories

This FOA solicits organ-specific applications for Biomarker Developmental Laboratories (BDLs), 1 of the 4 scientific units of the Early Detection Research Network (EDRN). Proposed BDLs must be focused on cancers of the breast, prostate and other genitourinary organs, and lung. Cancers with rapidly rising incidence rates (e.g., endometrial, hepatocellular, kidney, thyroid, oropharyngeal cancers, and/or cancers with unique etiology) will also be responsive.
Due Dates: Apr. 25 (Letter of Intent)
May 19 (OSR) Ι May 23 (Sponsor)
Amount & Project Period: $400,000/yr.(Direct Costs)-5 years(Mult. Labs/PI's)$250,000/yr. (Direct Costs) - 5 years (Single Lab/PI)
Eligibility: All Faculty Ranks - A  PD/PI may not serve as contact PD/PI on more than 1 application. Contact PDs/PIs of currently funded EDRN awards may not serve as a contact PD/PI on an application submitted to this FOA.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-009
R25 NIH
Education Project
April 25 (LOI) All Ranks Federal Genomics

Initiative to Maximize Research Education in Genomics: Courses

The over-arching goal of this NHGRI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral and clinical research needs.by supporting short, advanced level courses that are intended to disseminate new techniques, methods, and analyses related to the mission of the NHGRI. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.
Due Dates: Apr. 25 (Letter of Intent)
May 23 (OSR) Ι May 25 (Sponsor)
Additional Dates:  Sept. 25 & Jan. 25
Amount & Project Period: $50,000 (Direct Costs) An additional $5,000 in direct costs may be requested for the specific purpose of video recordings of lectures and/or hands on demonstrations - 3 years
Eligibility: The PD/PI should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI is expected to monitor & assess the program and submit all documents & reports as required.
Contact: Office of Sponsored Research (x6804)
FOA  Link: PAR-16-090
R25 NCI

NEW
April 25 (LOI)  All Faculty   Federal  Skills Development 

Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development

This program supports educational activities to enhance the diversity of the nation's biomedical, behavioral, and clinical research workforce.  Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients, as well as the cause and reduction of cancer health disparities in accordance with the overall mission of the NCI
Due Dates: Apr. 25 (Letter of Intent)
May 23 (OSR) Ι May 25 (Sponsor)
Additional due date: Sept. 25
Amount & Project Period: $300,000 direct cost/yr. - 5 years
Eligibility: All Faculty
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-139
Companion FOA:  PAR-16-138 (R25) (Research Experiences) 


NEW
April 25 Junior Faculty Non-federal Lung Cancer in Women

Bonnie J. Addario Lung Cancer Foundation
2016 Momentum Research Award: Defeating Lung Cancer In Women
A Joint Collaboration between the Bonnie J. Addario Lung Cancer Foundation and the American Lung Association

A research award to support novel, innovative and translational research with potential of high clinical impact in the early detection of lung cancer in women, as well understanding gender differences in lung cancer incidence, pathophysiology, treatment outcomes, and prognoses.
Due Dates: Apr. 21 16 (OSR) Ι Apr. 25 (Sponsor)
Amount & Project Period: $125,000/yr. - 2 years
Eligibility: Applicant must be w/in 5 years of first faculty appointment as of April 25, 2016.
Applicants who have completed 2 years of fellowship/post-doctoral training and are on track for faculty appointments are eligible to apply.
Investigators must be able to show clear evidence of a path towards an independent research program
Contact: Office of Sponsored Research (x6804)
Links: Guidelines Ι Research


April 26 Postdocs/Fellows/Junior Faculty Non-federal Career Development

Multiple Myeloma Research Foundation (MMRF)
2016 Research Fellow Award

The goal of this initiative is to help support young investigators to begin their studies in the field of multiple myeloma while advancing the understanding of myeloma disease biology, treatment and drug resistance.
Due Dates: Apr. 24 (OSR) Ι Apr. 26 (Sponsor)
Amount & Project Period: $75,000/yr. - 1 year
Eligibility: Post-doctorate, clinical fellow, or junior faculty levels are eligible and must work under the supervision of a research mentor/sponsor in the multiple myeloma field.
Contact: Office of Sponsored Research  (x6804)
Links: Guidelines | proposalCentral (Submission Site)
Admin. Supplement NCI
Division of Cancer Control and Population Sciences (DCCPS)
April 27 See Below Federal Health Disparities/Equity Research

Administrative Supplements for Collection and Analysis of Data and Biospecimens for Health Disparities/Equity Research

NCI's Division of Cancer Control and Population Sciences (DCCPS) announces an opportunity for supplemental funding to support:
(1) collection of new data (including linkages to other relevant databases or biospecimens) to augment existing study data;
(2) analysis of existing data addressing research gaps in cancer health disparities/equity; and
(3) exploratory research or research activities to strengthen the ability of existing studies to address research gaps in health disparities research and studies of understudied populations (rural, low SES, racial and ethnic groups).
Due Dates: Apr. 25 (OSR) Ι Apr. 27 (Sponsor)
Amount & Project Period: $150,000 (TOTAL) - 1 year
Eligibility: PIs can submit 1 administrative supplement per study
PI must have active R21, R01, P01, U01, or UM1 grant supported through NCI DCCPS. No other grant mechanisms are eligible for this program.
Parent grant must have sufficient time remaining to accommodate supplement. At least 1 full year must remain on the grant at the time of funding. Requests for no-cost extensions on the parent grant to accommodate a supplement will not be permitted.
Contact: Office of Sponsored Research  (x6804)
Link: Guidelines

April 27 (Pre-application) See Below Federal Breast

Congressionally Directed Medical Research Programs
Breast Cancer Research Program
Due Dates: Apr. 27 (Pre-application)
Invited Submissions: Aug. 09 (OSR) Ι Aug. 11 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: FY16 Breast Cancer Research Program
https://eBRAP.org (Pre-app. submission site)
Breakthrough Award Levels 3 & 4
W81XWH-16-BCRP-BREAKTHROUGH_FL34

Supports promising research having potential to lead to or make breakthroughs in breast cancer. Potential impact may be near-term or long-term, but must be significant and go beyond an incremental advancement. Partnering PI Option allows 2 PIs (Initiating and Partnering), to collaborate on a single application.
Amount & Project Period: The funding level should be selected based on scope of research project.
Level 3:  $2.5M (Direct Costs) - 4 years
Level 3 (Ptnr. PI):  $4.0M - 4 years (Separate awards made to each PI's institution)
Level 4 (Single or Ptnr. PI):  $10.0M - 4 years
Notes: An invited oral presentation is a requirement for application review of Funding Level 4 projects. Research milestones to be accomplished by the end of each year in the period of performance must be clearly defined in the project SOW and will be finalized during award negotiations.
Eligibility: All Ranks - Independent Investigators at all academic levels (or equiv.)
Link: Program Announcement

 

Innovator Award
W81XWH-16-BCRP-INNOV

Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field. Provides opportunity to pursue novel, visionary, high-risk ideas that will accelerate progress toward ending breast cancer. PIs must include breast cancer advocates on their research team.
Amount & Project Period: $5M (Direct Costs) - 4  years
Eligibility: Associate Professor or above (or equiv.);
PI must maintain 50% full-time effort during award period to breast cancer research;
Previous recipients of the BCRP Innovator Award are ineligible.
Link: Program Announcement
 

Distinguished Investigator Award
W81XWH-16-BCRP-DIA

Seeks new paradigms in breast cancer research by supporting investigators who are established and recognized leaders in their field and who propose a fundamental shift or leap beyond their existing track record of research.
Amount & Project Period: $3M (Direct Costs) - 4 years
Note:  Travel costs for PI to disseminate project results at DoD-required meeting in Yrs. 1 & 3. It should be assumed that meeting will be held in National Capital Area.
Eligibility: Assistant Professor or above (or equiv.)
Must be >6 years beyond last training position as of application submission deadline
Must include two or more breast cancer advocates on research team.
Link: Program Announcement
U01 NCI

April 27 (LOI) All Ranks Federal Cancer Care Delivery

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

This FOA encourages applications that strengthen the science of multilevel effects of cancer care interventions by addressing the problem of incomplete follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers.
Due Dates: Apr. 27 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Additional Dates:  Sept. 21; May 26 & Sept. 21, 2017
Amount & Project Period: $450,000 to $500,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-108


REMINDER - LOI must have been submitted to apply
April 28 All Faculty Ranks Moffitt Collaborative Research

Florida Academic Cancer Center Alliance (FACCA) Opportunity Pilot Awards

New collaborative projects involving Moffitt Cancer Center, UF Health Cancer Center at the University of Florida, and Sylvester Comprehensive Cancer Center at University of Miami. Designed to further build collaboration among the 3 centers, each of which is providing funding for the awards.   Each proposal requires strong, meaningful collaboration by investigators from at least 2 of the 3 Centers.
Due Dates: Applications due: Apr. 28 (OSR) OSR will forward for May 02 deadline.
Amount & Project Period: $50,000 per collaborating center per project - 12 months
Eligibility: All Faculty Ranks
Contact: Maureen Ahearn (x8824) for additional information, guidelines, & application
Links: FACCA Guidelines Ι  FACCA Application


NEW
April 28 (Pre-application) See Below Federal Ovarian

Congressionally Directed Medical Research Programs
Ovarian Cancer Research Program

Due Dates: April 28 (Pre-application)
Invited/Full Submissions:  Aug. 08 (OSR) Ι Aug. 10 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Links: FY16 Ovarian Cancer Research Program (OCRP)  https://eBRAP.org (Pre-app.)

Ovarian Cancer Academy Award - Early-Career Investigator
W81XWH-16-OCRP-OCA

This announcement solicits Early-Career Investigators to join the existing Academy.  This mechanism enables the Early-Career Investigator (PI on application) to pursue an ovarian cancer project that may be basic, translational, and/or clinical research, under the guidance of a Designated Mentor.
Amount & Project Period: $725,000 (Direct Costs) - 4 years
Eligibility: Must be w/in first 3 years of first faculty position (or equiv.) at time of submission. Position may be either tenure-track or non-tenure track;
May be a research or physician-scientist;
Must not have a concurrent Career Development-like award at time of this award.
Must have institutional commitment of approximately 50% protected time for ovarian cancer research and Academy activities including participation in monthly webinars.
Must commit no less than 25% effort to this award for the first 2 years
Links:   Program Announcement         

Pilot Award
W81XWH-16-OCRP-PA

Award supports exploration of innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward.
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Investigators at or above postdoctoral level (or equiv.)
Should have either dedicated or shared laboratory space
Links:  Program Announcement          
 

Clinical Development Award
W81XWH-16-OCRP-CDA

The goal is to accelerate the clinical introduction of medical products and technologies that target ovarian cancer biology. Near-term clinical impact is expected. Proof-of-concept demonstrating the potential utility of the proposed product or a prototype/preliminary version of the proposed product should already be established; thus, preclinical studies in animals are not allowed. Small-scale clinical trials (Phase 0, Phase 1, Pilot), studies enriching a clinical trial, and projects related to or associated with ongoing or completed clinical trials are allowed.
Amount & Project Period: $600,000 (Direct Costs) - 3 years
Eligibility: Independent investigator at or above the level of Assistant Professor (or equivalent)
Links: Program Announcement           
 

Investigator-Initiated Research Award
W81XWH-16-OCRP-IIRA

This award is intended to support high-impact research having potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project.
Amount & Project Period: $450,000 (Direct Costs) - 3 years
Eligibility: Independent investigator at or above Assistant Professor level (or equivalent)
Links:  Program Announcement

April 29, 3:00pm (EDT) All Faculty Non-federal Prostate Cancer

Prostate Cancer Foundation (PCF)  
2016 Challenge Awards  
For investigations of metastatic, lethal prostate cancer

 Research proposals in the following topic areas are preferred:
1.    New systemic treatments for metastatic, lethal prostate cancer incl. those targeting the 
       currently 'undruggable'.
2.    First-in-field research on new targets for systemic treatment of metastatic, lethal prostate
        cancer.
3.    Mechanisms of resistance to current and investigational drugs targeting the androgen
        receptor and androgen axis, immune system and chemotherapy.
4.    Correlative research around either clinical trials of novel agents or strategies or standard
        of care.
5.    Developing/validating biomarkers guiding therapy in patients or further understanding of
       mechanisms by which therapies work.
6.    Tumor microenvironment signaling related to cancer progression including the immune
       component.
7.    New bioinformatics technologies for analysis of genomic data.

Note:  A team is assembling for a Challenge Award submission on Immunotherapy of Prostate Cancer that will be co-funded by the V Foundation.  Please contact Dr. Julio Pow-Sang for information.
Due Dates: Apr. 27 (OSR) Ι Apr. 29, 3:00pm (EDT) (Sponsor)
Amount & Project Period: $1,000,000 (TOTAL) - 2 years
Eligibility: Teams are composed of at least three (3) investigators, including one young investigator
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFA Ι Submission Site


Updated
April 29 All Faculty Non-federal Basic & Translational

Worldwide Cancer Research
Research Grants

This organization funds research into any type of cancer.  The goal is to support research that will help reduce the incidence of cancer or improve cancer survival.  Grants are awarded for fundamental or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer.   This organization doesn't fund clinical research, (including clinical trials, patient care, nursing, healthcare delivery research), or applied cancer research such as policy, public health or psychosocial research.
Due Dates: Apr. 27 (OSR) Ι Apr. 29 (Sponsor)
Additional Due Date:  Oct. 28
Amount & Project Period: Max. £250,000 ($352,844 as of 04/08/2016) - 1 to 3 years
Eligibility: PI must be a suitably qualified researcher (minimum of PhD with 3 to 10  years research experience, or equivalent qualification or research experience, and usually a qualified tenured or tenure-track research group leader).
Contact: Office of Sponsored Research (x6804)
Links:  Overview | Grant Application Handbook


April 30 All Ranks Non-Federal Career Development

Chest Foundation

Due Dates: April 28 (OSR) Ι May 02 (Sponsor)
Eligibility: All Faculty Ranks
CHEST membership required at time of application.
Special consideration given to those w/in 5 years of completing an advanced training program.
Contact: Office of Sponsored Research (x6804)
Links: 2016 RFPs Ι Application Site

Research Grant in Lung Cancer
Supported by Genentech, Inc.

Award to support a research a project in lung cancer that leads to improved medical and/or surgical detection, treatment, and/or cure of lung cancer.  Higher level translational research project is preferred.  Basic (cellular/animal) research projects will not be considered.
Amount & Project Period: $90,000 (Total) - 2 years
 

Research Grant in Women's Lung Health
Supported in full by the CHEST Foundation

Responsive applications will address important and timely issues surrounding women's lung health, including  diseases such as COPD and lung cancer.
Amount & Project Period: $10,000 - 1 year
THE RETIREMENT RESEARCH FOUNDATION

NEW
May 01 All Ranks Non-federal Older Adults

The  Retirement  Research  Foundation
Responsive Grants Program

Grants will be awarded to projects that provide direct services, advocacy, education, and/or training programs for professionals working with elders, as well as for research that investigates causes and solutions to significant problems of older adults.
Due Dates: Apr. 28 (OSR) Ι May 01(Sponsor)
Additional Due Dates 2016:  Aug. 01
Amount & Project Period: $$not specified- generally 1-2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Responsive Grants

NEW
May 04 Junior Faculty Non-federal Career Development

Robert Wood Johnson Foundation
New Connections: Increasing Diversity of RWJF Programming

This program aims to expand the diversity of perspectives that inform RWJF programming and introduce new researchers to the Foundation to help address research and evaluation needs. New Connections is a career development program for early career researchers.
Due Dates: May 2 (OSR) Ι May 4 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Must have completed a doctoral degree w/in last 10 years (obtained by Sept 1, 2006 or later);
Must be early-career scholars, post-doc or assistant professor Must be from historically disadvantaged or underrepresented backgrounds in research disciplines;
Must be U.S. citizens, permanent residents, or individuals granted DACA status
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Funding Opportunity I FAQ

NEW
May 04 (LOI) All Ranks Non-federal PCOR

Patient-Centered Outcomes Research Institute
Pragmatic Clinical Studies to Evaluate Patient-Centered Outcomes - Cycle 2 2016

Funds pragmatic clinical trials, large simple trials, or large-scale observational studies comparing  two or more alternatives for addressing prevention, diagnosis, treatment, or management of a disease or symptom; improving healthcare system-level approaches to managing care; communicating or disseminating research results to patients, caregivers, or clinicians; or eliminating health or healthcare disparities.
Due Dates: May 04 (Letter of Intent)
Invited Applications:  Aug. 04 (OSR) Ι Aug. 08 (Sponsor)
Amount & Project Period: $10,000,000 (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview & Guidelines

May 6, 4:00pm Junior Faculty Moffitt Pilot Projects

MMG Junior Faculty Research Award

The MMG Junior Faculty Research Award (JFRA) is intended to ease the transition to independence for investigators either in the laboratory or as clinical trialists. The goal is to allow appropriate and motivated individuals to develop an independent research career in translational science focused on cancer.  It is intended that the MMG Junior Faculty Research Award will be used for research directly related to cancer investigation and must be translational or clinical in nature.
Due Dates: Friday, May 6, 2016 at 4:00pm EST
Amount & Project Period: $50,000 - 1 year
Eligibility: Instructor and Assistant Member levels
Contact: Jill Cass at Jill.Cass@moffitt.org or call 745-1387
Links: JFRA Guidelines  Ι  JFRA Application
R01 NIH
NCI is a participating Institute

NEW
May 07 All Ranks Federal Malignancies and HIV/AIDS

Research on Malignancies in the Context of HIV/AIDS

Research is encouraged in areas such as the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS defining and AIDS-defining malignancies in diverse populations. This FOA encourages research efforts that will (i) provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers.
Due Dates: May 05 (OSR) Ι May 07 (Sponsor)
Additional Dates:  Sept. 07 & Jan. 07
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-13-377
Companion FOA: PA-13-378  R21 Exploratory/Developmental Grant
R01 NIH
NCI is a participating Institute
May 07 All Ranks Federal HIV and Viral Hepatitis Co-Infection

Multidisciplinary Studies of HIV and Viral Hepatitis Co-Infection

The purpose is to fill gaps in our understanding of a) the pathogenic interactions between HIV and hepatitis viruses, b) co-morbidities associated with HIV/hepatitis virus co-infection, and c) the effectiveness of interferon-free direct-acting antiviral drug regimens to treat HIV/HCV co-infection.
Due Dates: May 05 (OSR) Ι May 07 (Sponsor)
Additional Dates:  Sept. 07 & Jan. 07
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-14-255
Companion FOA: PAR-14-254  R21 Exploratory/Developmental Grant


NEW
May 09 (LOI) See Below Non-federal Ovarian Cancer

Ovarian Cancer Research Fund Alliance

Due Dates: May 09 (Letter of Intent)
Invited Proposals:  July 20 (OSR) Ι Jul. 22 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: proposalCENTRAL
 

Ann Schreiber Mentored Investigator Award

This award provides funding for trainees who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research, or relevant area.
Amount & Project Period: $75,000 (Total) - up to 2 years
Eligibility: Must be either clinical fellows (Gynecologic Oncology, Medical Oncology) or postdoctoral fellows;
Must have M.D. or Ph.D. degree;
Applicants must be no more than 5 years out of their terminal degree at time of application (e.g. terminal degree must have been awarded during 2011 or later);
Applicants should be involved in either laboratory, clinical, or epidemiology research.
 

Collaborative Research Development Grant

The purpose is to provide funds for ovarian cancer research projects that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.  The selection committee will consider most favorably applications that are creative, original, and hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics.
Amount & Project Period: $300,000/yr. (Total) - 3 years
Eligibility: PI must have full-time faculty appointment; should not currently be in a training program.
 

The Liz Tilberis Early Career Award

This Award is for junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research. The intent is to support a substantial time commitment to research and academic endeavors in ovarian cancer.  Applications that are creative, original, and hold the most promise in the areas of early detection, prevention, treatment, and translational ovarian cancer research will receive  favorable consideration.
Amount & Project Period: $150,000/yr. (Total) - 3 Years
Eligibility: Applicants must have an M.D. or Ph.D. degree and sh/be in first 5 years of first academic appointment after having completed fellowship or postdoctoral training (Assistant Professor or equivalent). Individuals who will begin such a position by July 2016 are eligible
Applicants should have strong training in preparation for an investigative career in ovarian cancer research.
R01 NCI

NEW
May 09 All Ranks Federal HIV/AIDS Malignancies

Research on Malignancies in the Context of HIV/AIDS

This FOA encourages research efforts that will (i) provide information on clinical outcomes in the HIV-infected population and (ii) identify specific contributions resulting from HIV infection and its potential interaction with other pathogens for the development and pathogenesis of these cancers. 
Due Dates: May 05 (OSR) Ι May 09 (Sponsor)
This FOA expires Sept. 8, 2016
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-13-377
Companion FOA: PA-13-378 (R21) Exploratory/Developmental Grant

May 11, 2:30pm, ET All Ranks Non-federal Global Health

Bill & Melinda Gates Foundation
Global Grand Challenges
Grand Challenges Explorations Explore New Solutions in Global Health Priority Areas

Seeking innovative ideas to assess the burden of disease, to develop better vaccines, and to develop new diagnostics, to, among other challenges, enable self-testing for cervical cancer by seeking biomarkers that can be measured in simple-to-collect cervical, vaginal and urine specimens to diagnose women with cervical cancer or pre-cancer (histologically confirmed CIN2+ or higher lesions) in a screening population.  Preferred biomarkers will have preliminary clinical evidence that targeted biomarkers are non-inferior to current validated biomarkers, and can be reliably measured in less than two hours with minimal instrumentation and operator processing.
Due Dates: May. 09 (OSR) Ι May 11, 2:30pm, ET (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: The Opportunity Ι Application Instructions
Grant Application Tool Ι Rules & Guidelines

NEW
May 12 (LOI) Postdocs/Fellows Non-federal Career Development

amFAR Institute
Mathilde Krim Fellowships in Basic Biomedical Research

To facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research.
Due Dates: May 12 (Letter of Intent) Note:  Portal Log-in and Instructions required by May 10th, 12:30 PM EDT
Invited Applications:  Jul. 26 (OSR) Ι Jul. 28 (Sponsor)
Amount & Project Period: $150,000 (Total) - 2 years
Eligibility: Applicants must:
Hold a research or clinical doctorate completed between 3 and 6 years prior to April 14, 2016*
Be positioned to secure an independent research position no later than March 2019
Be mentored by an experienced investigator at the same institution who: (a) is qualified to oversee proposed research; (b) has successfully supervised postdoctoral fellows; and (c) is at associate professor level or higher.
Be the first author on significant publications in leading peer-reviewed journals Must have made oral and poster presentations at major scientific conferences and meetings *The 3 to 6 year period for applicants who have earned only an M.D./M.D. Ph.D. begins with the date they finished their internship.
Contact: Office of Sponsored Research (x6804)
Link: Overview & Guidelines
Admin. Supplement NCI

NEW
May 13 See Below Federal Health Disparities

Administrative Supplements to Generate Cancer Models to Advance Cancer Health Disparity Research

An opportunity is available for investigators with active NCI-supported research grants to request 1 year of supplemental funding in FY2016. NCI is interested in supplements that propose generation of cell or animal-based models that can be used to advance cancer health disparity research.
Due Dates: May 11 (OSR) | May 13 (Sponsor)
Amount & Project Period: $200,000 (Total) - 1 year
Eligibility: Investigators w/active NCI-supported research grants;
Research proposed must be accomplished w/in competitive segment of active award;
All supplement requests must propose activities w/in scope of parent award.
Contact: Office of Sponsored Research (x6804)
Links: NOT-CA-16-033 (Information)
PA-14-077 (Use this FOA to apply for supplement)



May 13, 12:00 (EDT) All Faculty Non-federal Myelodysplastic Syndromes

The Taub Foundation
Grants Program for Myelodysplastic Syndromes (MDS) Research

Supports high-impact, innovative translational research to understand underlying causes of MDS and to advance treatment and prevention.  The Program specifically focuses on MDS research, exclusive of AML and MPN.  Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged.
Due Dates: May 11 (OSR) Ι May 13, 12:00 (EDT) (Sponsor)
Amount & Project Period: $600,000 (TOTAL) - 3 years
Eligibility: Must hold  Ph.D., M.D., M.D./Ph.D., or equivalent degree
Must be independent investigators w/institutional support and their own laboratory
May not have funding support for a similar project U.S. Citizenship is not required; visa documentation is not required
Contact: Office of Sponsored Research (x6804)
Links: Overview | Online Portal for Application
S10 NIH

May 16 All Ranks Federal Equipment

Shared Instrumentation Grant (SIG) Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000.
Due Dates: May 14 (OSR) Ι May 16 (Sponsor)
Amount & Project Period: $600,000 (Max. Award) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-054
S10 NIH

May 16 All Ranks Federal Equipment

High-End Instrumentation (HEI) Grant Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,000.
Due Dates: May 14 (OSR) Ι May 16 (Sponsor)
Amount & Project Period: $2,000,000 (Max. Award) - 1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804) 
RFA Link: PAR-16-053
U01 NIH
NCI is a participating institute
May 18 All Ranks Federal Diagnosis & Treatment

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

FOA is accepting bioengineering applications to accelerate development and adoption of promising tools and technologies that can address important biomedical problems.  Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies, and engage biomedical researchers or clinicians throughout the project.  The goal of the program is to support projects that can realize meaningful solutions within 5 - 10 years.
Due Dates: May16 (OSR) | May 18 (Sponsor)
Additional 2016 Due Dates:  Sept. 13
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
FOA Link: PAR-16-116
Companion FOAs: PAR-13-137, R01 Bioengineering Research Grants (BRG)
PA-16-040,   R21 Exploratory/Developmental Bioengineering Research Grants (EBRG)


NEW
May 24 (LOI) All HOPA Members Non-federal Hematology/Oncology Pharmacy

The Hematology/Oncology Pharmacy Association (HOPA) Foundation
2016 HOPA Research Fund Award

To support a hematology/oncology pharmacy practice research project with subsequent publication.   Pharmacy practice is broadly defined including areas such as outcomes, surveys, patient safety, standards validation, and translational science applications. Multiple institutions may be involved in the project, and co-PI projects are allowed.
Due Dates: May 24 (Letter of Intent)
Invited Applications:  Sept. 01 (OSR) Ι Sept. 05 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Open to all HOPA members
Contact: Office of Sponsored Research (x6804)
Link: 2016 HOPA Research Fund Award
U01 NCI

NEW
May 24 (LOI) All Ranks Federal Clinical Assay Development

Integrating Biospecimen Science Approaches into Clinical Assay Development

This FOA will support extramural research to investigate and mitigate challenges facing clinical assay development due to biopsy biospecimen pre-analytical variability. The program will tie in with current efforts to optimize clinical biomarker assays utilized in NCI-sponsored clinical trials. 
Due Dates: May 24 (Letter of Intent)
Applications: June 20 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: Limited to $250,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks - A multidisciplinary research team is encouraged.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-166
R25 NCI
Cycle II Due Date
May 25 Associate/Full Members Federal Cancer Education

Cancer Education Grants Program  Curriculum or Methods Development

This FOA will support creative educational activities with a primary focus on Curriculum or Methods Development.   Applications that propose innovative, state-of-the-art programs, addressing the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients are encouraged.
Due Dates: May 23 (OSR) Ι May 25 (Sponsor)
Additional 2016 Due Date:  Sept. 25
Amount & Project Period: $100,000/year (Direct Costs) - 3 years
Eligibility: Established investigator at Associate Professor level or above in scientific area in which application is targeted, and capable of providing both administrative and scientific leadership to development and implementation of proposed program.
PD(s)/PI(s) with a currently funded NCI R25 award may submit an additional application in response to this FOA only if a new and innovative course that is distinctly different from the currently funded project is proposed.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-150
Companion FOAs: PAR-15-151, R25-Cancer Research Education Grants Program: Courses for Skills Development
PAR-15-152, R25-Cancer Research Education Grants Program:  Research Experiences
T32 NIH
NCI is a participating Institute
NEW
May 25 All Faculty federal Career Development

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant

Training grants enhance pre and postdoctoral research training, including short-term research training, and help ensure a diverse and highly trained workforce.  Training programs will incorporate didactic, research, and career development components.
Due Dates: May 23 (OSR) Ι May 25 (Sponsor)
Additional Due Dates:  Standard Dates
Amount & Project Period: Awards provide stipends for trainees, contribute to the cost of tuition & fees for trainees, and training-related expenses for trainees - 5 years
Eligibility: All Faculty - PD/PI should be an established investigator in scientific area in which application is targeted and capable of providing both administrative and scientific leadership to development and implementation of proposed program.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-152
U01 NCI

May 25 (LOI) All Ranks Federal Cancer Systems Biology

Emerging Questions in Cancer Systems Biology

This FOA solicits well-defined, discrete and circumscribed Research Projects addressing emerging problems in cancer as a part of a new Cancer Systems Biology Consortium (CSBC).  The consortium will include U54 CSBC Research Centers and a U24 CSBC Coordinating Center (see companion opportunities below). The CSBC initiative aims to address challenges in cancer Research through the use of experimental biology or population science combined with in silico modeling, multi-dimensional data analysis , and systems engineering.
Due Dates: May 25 (Letter of Intent)
June 22 (OSR) Ι June 24 (Sponsor)
Additional 2016 Due Date: Nov. 18
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks 
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-131
Companion Opportunities: RFA-CA-15-014 U54 Research Centers for Cancer Systems Biology Consortium
RFA-CA-15-015 U24 Coordinating Center for the Cancer Systems Biology Consortium and the Physical Sciences-Oncology Network




NEW
May 30 Faculty Federal HPV Prevention Network

HPV Roundtable: Creating a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination

The purpose is to develop and administer a national network of cancer prevention organizations to promote, in coordination with immunization stakeholders, efforts and activities to improve HPV vaccination delivery for the prevention of HPV-related cancers. This network will include cancer prevention stakeholders with channels to provide education, outreach, and training to the public and providers.
Due Dates: May 26 (OSR) Ι May 30 (Sponsor)
Amount & Project Period: $300,000 - $500,000
Eligibility: An organization that is:
1) national in scope and not limited to one locale, region, or state;
2) has a history of bringing targeted collaborative partners together (including regional and national organizations, key constituents, state and local governments) to accomplish objectives;
3) has expertise in assembling the resources needed to execute the particulars of the FOA; and
4) has capability of disseminating, publicizing, and promoting the outputs and other work to relevant parties and partners.
Contact: Office of Sponsored Research (x6804)
Link: CDC-RFA-IP16-1602PPHF16


May 30 All Faculty Non-federal Translational

Rising Tide Foundation for Clinical Cancer Research
Clinical Cancer Research

The overall goal of this cancer research funding program is to improve treatment options and quality of life for cancer patients by funding clinical studies focused on prevention, detection, treatments and aftercare.   It funds early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact.
Due Dates: May 30 (Letter of Intent) to be included in second funding cycle.  LOIs may be submitted at any time and date of receipt determines timing of review. If proposed project meets RTF funding criteria, an invitation will be sent to submit a full grant application for further consideration.
Amount & Project Period: Amount is based on the availability of funds. Duration is up to five years or less.
Eligibility: All Faculty
Contact: Office of Sponsored Research (x6804)
Links: Overview - How to Apply
Clinical Cancer Research Programmatic Guidelines
Proposal Central (Submission site)
R01 NCI

NEW
May 30 (LOI) All Ranks Federal NCI Provocative Questions

Revision Applications to R01 Awards for Research on the NCI's Provocative Questions

This FOA invites revision applications from PIs w/active NIH R01 grants.  Applications must focus on research related to one of the Provocative Questions (PQs) published for new applications in RFA-CA-15-008 and RFA-CA-15-009.  Research is encouraged that directly addresses PQs, including research that helps validate PQ research outcomes or adopts and disseminates PQ research results that impact cancer research and clinical care. Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent R01 award.
Due Dates: May 30 (Letter of Intent)
June 24 (OSR) Ι June 28 (Sponsor)
Additional Due Date:  Oct. 28
Amount & Project Period: $150,000/yr. (Direct Costs) - up to 2 years
Eligibility: All Ranks
PD/PI (or Contact PD/PI for MPI awards) on parent award must be the same on revision application.
R01 research grants w/at least 2 years remaining at time of award.
Application must specifically address a particular scientific problem identified as one of the PQs exactly as defined in this FOA
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-010
Companion RFAs: RFA-CA-16-011, Revision Applications to U01 Awards for Research on the NCI's Provocative Questions
RFA-CA-16-013, Revision Applications to P01 Awards for Research on the NCI's Provocative Questions
RFA-CA-16-012, Revision Applications to P50 Awards for Research on the NCI's Provocative Questions


May 31 ALL Ranks Non-federal Culture of Health

Robert Wood Johnson Foundation
Global Ideas for U.S Solutions

Looking for projects, programs, and models that promote health equity and are aligned with our Culture of Health Action Framework; current year interests in ideas that: Build healthy places; Build social connection across the lifespan; Get and keep children healthy; Integrate health and social services; and Increase the health care system's focus on the root causes of poor health.
Due Dates: May 27 (OSR) I May 31 (Sponsor)
Amount & Project Period: $50,000 up to $250,000 -  up to 18 months
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Guidelines
U01 NCI

May 31 (LOI) All Ranks Federal Combined Modality Treatment
 of Solid Tumors

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy

For studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. The overall goal is to accelerate the pace at which combined modality treatments with greater efficacy are identified and incorporated into standard practices for treatments of patients with solid tumors.
Due Dates: May 31 (Letter of Intent)
Full Applications: Jul. 12 (OSR) Ι Jul. 14 (Sponsor)
Additional Due Dates: Dec. 14; Jul 14 & Dec. 14, 2017
Amount & Project Period: Not to exceed $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-111


NEW
June 01 Postdocs/Junior Faculty Federal Career Development

The Air Force Research Laboratory (AFRL)
Air Force Office of Scientific Research (AFOSR)
Air Force Fiscal Year 2017 Young Investigator Research Program (YIP)
BAA-AFRL-AFOSR-2016-0006

The objective of this program is to foster creative basic research in science and engineering; enhance early career development of outstanding young investigators.  See areas of interest identified in the most recent Broad Agency Announcement titled "Research Interests of the Air Force Office of Scientific Research"
Due Dates: May 27 (OSR) Ι June 01 (Sponsor)
All technical or general pre-proposal inquiries & questions must be submitted by Monday, May 2nd.
Amount & Project Period: $120,000/yr. (Total) - 3 years
Eligibility: Scientists who have received PhD or equivalent degrees April 1, 2011 or later
Must hold full-time permanent, career-competitive, or tenure-track position, or 
Proposal must include a letter from organization confirming consideration for such an appointment.
Must be a U.S. citizen, national, or permanent resident.
Contact: Office of Sponsored Research (x6804)
Link: Full Announcement


NEW
June 01 All Faculty Non-federal Treatments & Cures

Elsa U. Pardee Foundation
Cancer Research

The Foundation supports research directed toward identifying new treatments or cures for cancer.  It  encourages  applications which will allow establishment of capabilities of new cancer researchers,  or new cancer approaches by established cancer researchers.
Due Dates: May 27 (OSR) Ι June 01 (Sponsor)
Additional 2016 Due Date:  Oct. 01
Amount & Project Period: Amount varies, dependent on project  - 1 year
Eligibility: All Faculty
Contact: Office of Sponsored Research  (x6804)
Link: Grant Application Process

and
June 02 All Ranks Non-federal Pediatric Brain Cancer

The Cure Starts Now Foundation
Research Grants

Funds search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers Focus is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support translational and clinical research projects in those areas.
Due Dates: May 30 (OSR) Ι June 01 (Sponsor) Ι Hardcopy due June 05
Amount & Project Period: $100,000 (TOTAL) - 1 year
Eligibility: All Ranks
Contact: Mary Newton (x3658) for writing assistance. 
All completed applications must be approved and submitted through the Office of Sponsored Research (x6804).
Links: Research & Grants
Grant Application Information
Electronic Submission

NEW
June 03, 4:00pm Staff/Research Scientists & All Faculty Moffitt Core Projects

Innovative Core Projects Award

The Innovation and Technology Committee (ITC), co-chaired by Dr. Mulé and Dr. Koomen, is pleased to announce the Innovative Core Projects Funding Opportunity.   With a goal to enhance our institutional innovation, this award is meant to encourage early access to novel technologies before commercially available and further Moffitt's efforts to remain on the forefront of discovery.
Due Dates: June 03 (4:00pm)  All applications along with the Institutional Proposal Submission Form must be submitted to the Office of Sponsored Research for review two days prior to the application due date.
Amount & Project Period: $60,000 - 12 months
Eligibility: This funding opportunity is open to Moffitt faculty as well as Staff Scientists and Research Scientists.
Contact: Brittany Palermo (x1536)
Links: Innovative Core Projects Funding Guidelines  Ι  Face Page
R01 NIH

NEW
Parent R01
June 05 All Ranks Federal Research Projects

NIH Research Project Grant

The current Parent R01 expires May 10, 2016 and is replaced by PA-16-160.  The new FOA was posted on March 31st and the earliest submission date is May 05, 2016.
Due Dates: June 02 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard Dates Apply
Amount & Project Period: Modular Budget:  $250,000/yr. (Direct Costs) - 5 years
Detailed Budget:  Not Limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-160
R01 NIDCR

NEW
June 06 All Ranks Federal Immune System Plasticity

Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases

 The purpose is to encourage research projects elucidating the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases.
The goal is to advance knowledge of the immunological basis of dental, oral, and craniofacial diseases, and to develop tools and technologies for precise modulation of the immune system to restore or maintain health.
The expectation is that new knowledge derived from this research will facilitate development of novel immunomodulatory therapies to prevent disease onset or reverse disease progression.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional Due Dates: Standard Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-192
Companion FOA: PAR-15-193 (R21) Exploratory/Developmental Grant
R01 NCI

June 06 All Ranks Federal Physical Activity/Weight Control

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival

This FOA encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival.
Due Dates: June 03 (OSR Ι June 06 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budget not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-122
Companion FOA: PAR-16-123 (R21)
R01 NCI

June 06 All Ranks Federal Diagnosis & Treatment

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

Applications are encouraged from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.  Partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem.  FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work.
Due Dates: June 03 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:  Standard dates apply
Amount & Project Period: Application budget not limited - 5 years
Eligibility: All Ranks 
Contact: Office of Sponsored Research - (x6804)
FOA Link: PAR-15-075
R01 NCI

NEW
June 06 All Ranks Federal Early Life Factors & Cancer

Early-life Factors and Cancer Development Later in Life

Supports research focused on role of early-life factors in cancer development later in life.  It is necessary to better understand
1) Early-life (maternal-paternal, in utero, birth and infancy, puberty and adolescence, and teenage and young adult years) factors associated with later cancer development;
2) How early-life factors mediate biological processes relevant to carcinogenesis; and
3) Whether predictive markers for cancer risk based on what happens biologically at early-life can be measured and developed for use in cancer prevention strategies.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:  Standard Dates Apply
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-15-126
Companion FOAs: PA-15-125, R21 Exploratory/Developmental Grant
PA-15-124, R03 Small Grant Program
R01 NIH
NCI is a participating Institute

NEW
June 06 All Ranks Federal Population Health Interventions

Population Health Interventions: Integrating Individual and Group Level Evidence

The purpose of this FOA is to support multilevel, transdisciplinary population health interventions that target underlying social, economic, and environmental conditions in an effort to improve health outcomes.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional Due Dates:  Standard Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-146
Companion FOA: PA-16-147 (R21)
R01 NIH
NCI is a participating Institute
NEW
June 06  All Ranks  Federal Diet and Physical Activity

Obesity Policy Evaluation Research

This FOA encourages applications that propose to evaluate policies or large scale programs that are expected to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes have the potential to prevent or reduce rates of obesity.  NCI is particularly interested in the evaluation of programs or policies that may affect dietary or physical activity behavior and/or weight, and studies incorporating economic research.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional 2016 Due Dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-165
R01 NIH
NCI is a participating Institute
NEW
June 06 All Ranks Federal Diet & Physical Activity

Diet and Physical Activity Assessment Methodology

 The overarching goal is to provide support to promote  early and conceptual stages of research efforts on novel scientific ideas having potential to substantially advance cancer research, such as improving epidemiologic study data collection; validating measurement of exposures in body fluids and tissues; applying epigenetic or metabolomic approaches to cancer epidemiology research; developing and applying novel strategies for discovery of risk variants for rare cancers; understanding the population genetic architecture of cancer in understudied populations; or validating methods to extract, collect, and synthesize clinical data via electronic medical records for use in observational studies of cancer patients and survivors.
Due Dates: June 02 (OSR) Ι June 06 (Sponsor)
Additional 2016 Due Dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-167
Companion FOA: PAR-15-171 (R21 Exploratory/Developmental Grant)


June 06 All Faculty Non-federal Translational Research

The Harrington  Discovery Institute
Scholar-Innovator Award

This Award recognizes physician-scientist innovators throughout the U.S. whose research has the potential to change standard of care. The Scholar-Innovator Award provides research and drug development funding as well as non-financial support to selected innovators and their institutions to help bridge the gap between basic discovery and clinical introduction.
Due Dates: June 2 (OSR) Ι June 6 (Sponsor)
Submissions will be completed online at HarringtonDiscovery.SmartSimple.com
Amount & Project Period: $100,000  - 1 year.   See program description for additional information
Eligibility: Hold an MD or MD/PhD;
Hold a faculty position;
May have only a single PI;
Past recipients of the Harrington Scholar-Innovator Awards may submit new & distinct proposal but may not seek additional support for previously funded projects.
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι Grant Program Details Ι Program Policies

NEW
June 08 (Pre-application) Postdocs/Fellows Federal Career Development

NIH Director's Early Independence Award (DP5)
Limited Submission - Requires Moffitt pre-application

Opportunity for outstanding  junior investigators to accelerate entry into an independent research career by forgoing traditional post-doctoral training to pursue independent research directly after completion of terminal doctoral degree or clinical residency.
Due Dates: June 08, 4:00pm
(Pre-application to include: 1 page letter of introduction & 2-page research outline submitted electronically to Maureen.ahearn@moffitt.org (PDF format only))
Amount & Project Period: $250,000/yr. (Direct Costs) - 5 years
Eligibility: At time of application, candidate must be w/in 1 year (before or after) of completing a terminal degree or clinical residency, and must not be in an independent position
Contact: Maureen Ahearn (x8824)
RFA Link: RFA-RM-16-006


NEW
June 09 (Pre-applications) See Below Federal Lung

Congressionally Directed Medical Research Programs (CDMRP)
Lung Cancer Research Program (LCRRP)

Due Dates: June 09 (Pre-application)
Invited Submissions:  Sept. 12 (OSR) Ι Sept. 14 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: FY16 Lung Cancer Research Program (LCRP)
https://eBRAP.org (Pre-app.)
 

Career Development Award
W81XWH-16-LCRP-CDA

Supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher; preliminary data not required.
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Must be independent investigator at level of Assistant Professor, Instructor, or equiv.;
Must be w/in 5 years of first faculty appointment (or equiv.), and exhibit a strong desire to pursue a career in lung cancer research.
Mentor: At or above the level of Associate Professor (or equivalent); have a proven publication and funding record in lung cancer research
Link: Program Announcement
 

Idea Development Award
W81XWH-16-LCRP-IDA

Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research; emphasis on innovation and impact; New Investigator category supports applicants early in their faculty appointments or in the process of developing independent research careers; preliminary data required, but may be from outside of lung cancer.
Amount & Project Period: $350,000 (Direct Costs) - 2 years
Eligibility: Although a PI may be eligible for both the New Investigator and Established Investigator categories, the PI can choose only one category under which to apply.
Established Investigators: Independent investigators at or above the level of Assistant Professor (or equivalent); or
New Investigators: Investigators that meet the following criteria at the application submission deadline date:
     Have not previously received a LCRP Idea Development 
     Award or Early Investigator Synergistic Idea Award   
     Independent investigators at or above Assistant Professor
     (or equivalent) and be w/in 10 years of first faculty
     appointment (or equivalent)
Link: Program Announcement
 

Clinical Exploration Award
W81XWH-16- LCRP-CEA

Supports rapid execution of hypothesis-driven, early-phase clinical trials to examine interventions that could have a major impact on lung cancer clinical management. Application must include documentation of an existing Investigational New Drug (IND) or Investigational Device Exemption, if applicable.
Proposed study is expected to begin no later than 12 months after award date.
Amount & Project Period: $550,000 (Direct Costs) - 3 years
Eligibility: Independent investigators at or above the level of Assistant Professor (or equivalent)
Link: Program Announcement
 

Investigator-Initiated Translational Research Award
W81XWH-16-LCRP-IITRA

Supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Mechanism is intended to fund a broad range of translational studies, including, but not limited to:
     Studies advancing/translating in vitro and/or animal studies to applications w/human
     samples/cohorts.
     Late-stage preclinical work leading to/preparing for a clinical trial
     Correlative studies associated with an ongoing or completed clinical trial and
     projects that develop endpoints for clinical trials.
Amount & Project Period: $400,000 (Direct Costs) - 2 years
Eligibility: Independent investigators at or above the level of Assistant Professor (or equivalent)
Link: Program Announcement

NEW
June 10 Junior Faculty Non-federal Research Support

Vilcek Foundation
The Vilcek Prize for Creative Promise in Biomedical Science

Prizes are awarded to young foreign-born biomedical researchers who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science.
Due Dates: June 08 (OSR) Ι June 10 (Sponsor)
Amount & Project Period: $50,000
Eligibility: Must have been born outside the United States;
Must not be more than 38 years old as of December 31, 2016 (born on or after January 1, 1978);
Must be a naturalized citizen of the United States;
     or be a permanent resident (green card holder) of U.S.
     or be a holder of an H1B or O-1 visa and have been living  
     and working in the U.S. for at least 5 years; or have been
     granted Deferred Action for Childhood Arrivals (DACA); Eligible positions include the following: assistant or associate professor, research scientist, or equiv.;
Must have earned degree (MD, PhD, or equiv.);
Must intend to pursue professional career in U.S.;
Must hold full-time position
Contact: Office of Sponsored Research (x6804)
Links: Vilcek Foundation Ι Guidelines
U01 NCI
Research Projects-Cooperative Agreement

 
June 11 (LOI) All Ranks Federal Imaging & Biomarkers

Imaging and Biomarkers for Early Detection of Aggressive Cancer

This FOA invites applications for collaborative research projects to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk and cancer diagnosis aimed at integrating multi-modality imaging strategies and multiplexed biomarker methodologies into a singular complementary approach.
Due Dates: June 11 (Letter of Intent)
Jul. 09 (OSR) Ι Jul. 11 (Sponsor)
Additional Due Date in 2016:  Dec.14
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-089
K18 NIDCR

NEW
June 13 Established Investigators Federal Career Enhancement

Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators

This FOA encourages applications for short-term mentored career enhancement awards in dental, oral and craniofacial research w/a focus on behavioral and social sciences, and genetic and genomic research.   The intent is to provide mid-career or senior investigators with short-term training in the theories, tools, methods or approaches of another scientific area, in order to enhance their existing research program.
Two categories of candidates are targeted:
      (a) Established dental, oral, and craniofacial research investigators seeking training
      w/investigators from another field, in order to enrich their existing dental, oral and
      craniofacial research program; and
      (b) Established investigators in other fields who seek training with dental, oral and
      craniofacial research investigators in order to facilitate the introduction of dental, oral
      and craniofacial research into an existing research program.
Due Dates: June 09 (OSR) | June 13 (Sponsor)
Additional Due Dates: Standard Dates
Amount & Project Period: NIDCR will contribute a min. 20% up to a max. 50%/yr.  to the salary of the career award recipient, and $25,000/yr. toward research development costs.
A project period from 2.5 months to 12 months may be requested
Eligibility: Must have a research or health professional doctoral degree, or a combined health-professional and research doctoral degree.
Intended for well-established investigators at academic rank of Associate Professor or Professor, or equiv., who have established records of independent, peer reviewed Federal or private research grant funding.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-179

NEW
June 15 Postdocs Non-federal Neurobiology

The International Eppendorf & Science Prize for Neurobiology

An international award which honors young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology.
Due Dates: June 15 (Sponsor)
Amount & Project Period: $25,000 award plus full support to attend the Prize Ceremony held in conjunction with the Annual Meeting of the Society for Neuroscience in the USA and an invitation to visit Eppendorf in Hamburg, Germany
Eligibility: Must be a neurobiologist w/advanced degree received in last 10 years, and not older than 35 years of age.
Entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology. Entrant must have performed or directed work described in the essay.
Research must have been performed during the previous three years.
Link: Application Guidelines
R21 NIH

NEW
June 16 All Ranks Federal Epidemiology and Genomics

Exploratory Grants in Cancer Epidemiology and Genomics Research

The overarching goal is to provide support to promote  early and conceptual stages of research efforts on novel scientific ideas having potential to substantially advance cancer research, such as improving epidemiologic study data collection; validating measurement of exposures in body fluids and tissues; applying epigenetic or metabolomic approaches to cancer epidemiology research; developing and applying novel strategies for discovery of risk variants for rare cancers; understanding the population genetic architecture of cancer in understudied populations; or validating methods to extract, collect, and synthesize clinical data via electronic medical records for use in observational studies of cancer patients and survivors.
Due Dates: June 14 (OSR) Ι June 16 (Sponsor)
Additional 2016 Due Dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-175
R21 NCI

NEW
June 16 All Ranks Federal RBA Modifications in Cancer Biology

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology

This FOA encourages basic research into the role of RNA chemical modifications and their corresponding writers, readers and erasers in the initiation and progression of cancer.
Due Dates: June 14 (OSR) Ι June 16 (Sponsor)
Additional 2016 Due Dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-177


NEW
June 19 Clinical Faculty Non-federal Duvelisib

National Comprehensive Cancer Network® (NCCN®)
Treatment of Hematologic Malignancies

The overall aim is to develop innovative studies of Duvelisib in hematologic malignancies.   Collaborative studies between NCCN Member Institutions are encouraged.
Due Dates: June 16 (OSR) Ι June 19 (Sponsor)
Amount & Project Period: Phase I and Single-arm Phase II clinical trials funding should not exceed $500,000. Clinical study max. $300,000 + correlative study max. $100,000 + multi-institutional funding max. $100,000 = $500,000 MAX. funding - 2 years
Eligibility: Clinical Faculty
Contact: Office of Sponsored Research (x6804)
Link: NCCN Oncology Research Program


NEW
June 20 Faculty Non-federal Women's Cancers

The Foundation for Women's Wellness
Research Awards

These research awards target early funding for small, short-term studies that hold promise for improving medical knowledge in female cancers.  Desired research proposals have direct clinical application in preventing and/or treating disease; studies with the promise of yielding results that will attract larger sources of funding for advancing study; and influencing long-term research directions in its field.
Due Dates: June 16 (OSR) Ι June 20 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: Must be an M.D. and/or Ph.D. with a faculty appointment (investigator, assistant professor, or higher)
Contact: Office of Sponsored Research (x6804)
Link: Research Awards
R01 NIH
NCI is a participating institute
June 21 All Ranks Federal Drug Delivery

Image-guided Drug Delivery

Funding will support innovative research projects that are focused on image-guided drug delivery (IGDD), including real-time image guidance, monitoring, quantitative in vivo characterizations and validation of delivery and response.  It will support research in development of integrated imaging-based systems for delivery of drugs or biologics in cancer and other diseases, quantitative imaging assays of drug delivery, and early intervention.
Due Dates: June 19 (OSR) Ι June 21 (Sponsor)
Note: Additional due date in 2016:  Nov. 22
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-044
R21 NCI

June 22 All Ranks Federal Career Development

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research

Supports eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences workforce, and provides a bridge to investigators that have completed their research training and may need extra time to develop a larger research project grant application.
Due Dates: June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-053


June 30 All Faculty Non-federal Children's Leukemia

Children's Leukemia Research Association (CLRA)
Research Grants

These research grants are for doctors who are conducting the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Dates: Mar. 02 (OSR) Ι Mar. 04 (Sponsor)
Amount & Project Period: $30,000 - 1 year
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Application


NEW
July 01 Postdocs Non-federal Career Development

The Helen Hay Whitney Foundation
Research Fellowship

Grants financial support of sufficient duration to help further the careers of young men and women engaged in basic biological or medical research. 
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: Yr. 01:  $51,000 (Stipend) - $1,500 (Allowance)
Yr. 02:  $52,000 (Stipend) - $1,500 (Allowance)
Yr. 03:  $53,000 (Stipend) - $1,500  (Allowance)
Eligibility: Hold, or be in final stages of obtaining Ph.D., M.D., or equivalent;
Have <1 year of postdoctoral research experience as of due date and have received a PhD <2 years before due date, or M.D. degree <3 years before due date
Contact: Office of Sponsored Research (X6804)
Link: Research Fellowships


July 01 Junior Clinical Faculty Non-federal Career Development

Damon Runyon Cancer Research Foundation
Rachleff Innovation Award

The goal is to fund high-risk/high-reward research that lacks sufficient preliminary data to secure traditional funding.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: $300,000 (Total) - 2 years
Note: Continued support for years 3 and 4 will be granted to those awardees who demonstrate progress on their proposed research during years 1 and 2.
Eligibility: Applicants must belong to 1 of the following:
Tenure-track Assistant Professors w/in first 4 years of initial Asst. Professor appt. (Cut-off date: July 1, 2012.)
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD who are pursuing a period of independent research before taking a tenure-track faculty position.  Such individuals must have an exceptional record of research accomplishment, dedicated laboratory space and support of their institution.
Note: Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows are not eligible. 
Applicants are expected to commit a minimum of 80% effort to research
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines

July 01 All Ranks Non-federal Cutaneous

American Society for Dermatologic Surgery
Cutting Edge Research Grant Program (CERG)  

Submission of well-conceived research projects is encouraged.  Specifically encouraged are proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in:  Cosmetic medicine and surgery; Core surgical procedures and techniques; Cutaneous oncology; and  new technologies.
Due Dates: June 29 (OSR) Ι Jul. 01(Sponsor)
Amount & Project Period: $20,000 - 1 year
Eligibility: All Ranks;
PD/PI must be ASDS member
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι 2016 Application Site




July 01 All Ranks Non-Federal Clinical Oncology

The Hope Foundation
Early Exploration and Development (SEED) Fund

To encourage preliminary research that will translate to clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN).  Awards may assist investigators with projects that support the following types of studies: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: June. 29 (OSR) Ι Jul. 01. 5:00, pm ET) (Sponsor)
Additional Due Date:  December 01
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Any SWOG investigator
Contact: Office of Sponsored Research (x6804)
RFA Link: Research & Funding Ι Announcement
R44 NCI

NEW
July 13 See Below Federal Commercialization

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics and Prognostics Toward Commercialization

Additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency.  Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose is to facilitate transition of SBIR or STTR Phase II projects to the commercialization stage.
Due Dates: Jul. 11 (OSR) Ι Jul. 13 (Sponsor)
Amount & Project Period: $1,000,000/yr.  (Total) - 3 years
Eligibility: Organized for profit, w/place of business in the U.S.
Has (including affiliates), no more than 500 employees.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-16-008

NEW
August 5  All Ranks  Non-Federal  Mesothelioma 

The Meso Foundation (formerly known as MARF)
Mesothelioma Research Funding  

Proposed projects may relate to benchwork, translational or clinical research not presently funded.  Encouraged projects include, but are not limited to:
1.   Strategies for early detection and prevention of mesothelioma;
2.   Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment taking advantage of these targets;
3.   Determination of clinical/molecular determinants for prognosis
4.   Therapeutic intervention, including but not limited to:    
       a.   Immune Response Targeted Therapy
       b.   Novel chemotherapeutic compounds
       c.    Novel radiation or surgical techniques
Due Dates: Aug.03 (OSR) Ι Aug.05 (Sponsor)
Amount & Project Period: Up to $50,000/yr. - 2 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org